SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-017288
Filing Date
2023-06-13
Accepted
2023-06-13 17:02:55
Documents
1
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3662
  Complete submission text file 0001437749-23-017288.txt   5034
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO.10, UNIT 1, LIJING VILLA TIANZHU, SHUNYI DISTRICT BEIJING F4 101316
Business Address
Zheng Yongxiang (Reporting) CIK: 0001910375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 231012039